Almoosa Health Company Cash Flow Statement

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	208.57	94.42	98.15	51.02	62.42	104.77
Depreciation & Amortization	91	81.73	64.76	56.94	28.49	23.36
Other Amortization	2.53	2.62	3.53	2.65	1.46	1.58
Loss (Gain) From Sale of Assets	-0.19	-0.11	-0.33	-0.03	0.07	-0
Asset Writedown & Restructuring Costs	-	-	-	0.01	0.01	0.55
Loss (Gain) on Equity Investments	-0.96	-1.19	-	-	-	-
Provision & Write-off of Bad Debts	3.81	4.41	3.93	-0.17	1.22	0.15
Other Operating Activities	29.05	25.38	10.36	14.93	12.08	-2
Change in Accounts Receivable	-207.18	-42.3	-166.81	-66.22	-10.71	-28.82
Change in Inventory	-2.28	-8.81	-9.29	-0.16	-7.77	-6.47
Change in Accounts Payable	19.47	42.92	3.15	-49.76	75.25	80.92
Change in Other Net Operating Assets	13.6	-15.38	32.62	-20.19	35.21	-24.13
Operating Cash Flow	159.22	183.68	40.07	-10.97	197.72	149.92
Operating Cash Flow Growth	-9.95%	358.41%	-	-	31.88%	-
Capital Expenditures	-480.33	-240.34	-383.19	-307.18	-318.47	-436.81
Sale of Property, Plant & Equipment	1.41	1.36	23.07	0.03	0.02	0.04
Sale (Purchase) of Intangibles	-3	-6.33	-2.16	-2.89	-0.31	-1.12
Sale (Purchase) of Real Estate	-16.93	-16.93	-92.1	-	-	-
Investment in Securities	-88.65	-	-	-	3.28	-
Investing Cash Flow	-587.49	-262.23	-454.39	-310.04	-315.49	-437.89
Long-Term Debt Issued	-	305.59	622.91	285.67	148.91	290.53
Short-Term Debt Repaid	-	-	-	-	-	-1
Long-Term Debt Repaid	-	-190.67	-208	-7.54	-7.54	-0.75
Total Debt Repaid	-866.3	-190.67	-208	-7.54	-7.54	-1.75
Net Debt Issued (Repaid)	-621.3	114.92	414.92	278.13	141.38	288.78
Issuance of Common Stock	1,182	-	-	-	-	5
Common Dividends Paid	-70.89	-14.01	-	-	-15.66	-
Financing Cash Flow	448.99	100.92	414.92	278.13	125.71	293.78
Net Cash Flow	20.73	22.36	0.6	-42.88	7.94	5.81
Free Cash Flow	-321.11	-56.66	-343.12	-318.15	-120.76	-286.89
Free Cash Flow Margin	-23.60%	-4.71%	-35.05%	-38.99%	-17.21%	-45.61%
Free Cash Flow Per Share	-7.68	-1.62	-9.80	-9.09	-1207.55	-
Cash Interest Paid	23	78.55	24.02	10	1.14	1.44
Levered Free Cash Flow	-435.02	-112.73	-369.73	-359.89	-122.63	-
Unlevered Free Cash Flow	-415.81	-63.42	-357.82	-351.6	-121.7	-
Change in Working Capital	-176.39	-23.57	-140.33	-136.33	91.98	21.51

Source: S&P Global Market Intelligence. Standard template. Financial Sources.